Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure
NCT: NCT04452149 · COMPLETED
Brief Summary
The ALLEVIATE-HF study is a prospective, randomized, controlled, blinded, multi-site, interventional, investigational device exemption (IDE) pivotal study. The purpose of the study is to demonstrate the safety and efficacy of a patient management pathway that utilizes an integrated device diagnostic-based risk stratification algorithm to guide patient care in subjects with NYHA class II and III heart failure, and to demonstrate the safety of the Reveal LINQ™ system and procedure in the study population.
Frequently Asked Questions
What is Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure?
Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure is a clinical trial registered under NCT04452149. Current status: COMPLETED.
What is the status of NCT04452149?
The current status of NCT04452149 (Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure) is: COMPLETED.
When did Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure start?
Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure started on 2020-09-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.